Diadem Spa和UT研究人员在CTAD 2024公布了一个新的抗体,用于早期检测阿尔茨海默氏病。 Diadem SpA and UT researchers unveiled a new antibody for early Alzheimer's detection at CTAD 2024.

Diadem Spa与得克萨斯大学医学系的研究人员合作,在2024年CTAD会议上介绍了早期阿尔茨海默氏病检测的重要结论。 Diadem SpA, in partnership with researchers from the University of Texas Medical Branch, presented significant findings on early Alzheimer's disease detection at the 2024 CTAD conference. 他们开发了一种U-p53AZ特有的抗体,该抗体辨别了脑组织中P53蛋白质的错误折叠变体,区分了阿尔茨海默氏病患者和健康个体。 They developed a U-p53AZ-specific antibody that identifies a misfolded variant of the p53 protein in brain tissue, distinguishing Alzheimer's patients from healthy individuals. 这项研究突出了抗体在改进老年痴呆病早期诊断和治疗战略方面的潜力。 This research highlights the antibody's potential for improving early diagnosis and therapeutic strategies for Alzheimer's disease.